Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SABRATEK CORP (SBTK) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Terf who wrote (447)	8/24/1999 12:49:00 AM
From: Pluvia	Read Replies (2) \| Respond to of 487

ATTENTION WADE H. KING M.D. (BancBoston Robertson Stephens senior medical device and medical technology analyst) 1. PLEASE EXPLAIN TO THE INVESTORS WHO TOOK YOUR ADVICE LESS THAN 60 DAYS AGO WHY SBTK IS NOW DOWN 90%? 2. PLEASE EXPLAIN WHAT RELATIONSHIP YOUR FIRM HAS WITH SBTK AND HOW MUCH BancBoston Robertson Stephens WAS PAID BY SBTK FOR BANKING WORK OVER THE LAST 5 YEARS... 3. PLEASE EXPLAIN WHY YOU DESERVE A JOB AS AN ANALYST. 4. PLEASE EXPLAIN WHY YOUR FIRM HAS NOT CHANGED ITS RATING ON SBTK NOW THAT THE COMPANY IS FALLING APART? As a reminder maybe you can read over part of your BUY rec from less than 60 days ago.... "We reiterate our Buy rating on the company's shares. Our new 1999 price target is $34, 25 times our 2000 earnings per share estimate of $1.35. Currently, the stock is trading at only 16.6 times our 2000 EPS estimate, offering investors at current prices the opportunity for more than 50 percent return on investment," said King. AND ONE LAST THING - DR. WADE... ARE YOU A MOOOO-RON? Congratulations for bamboozling hundreds of investors out of their hard earned money. You and your firm are a disgrace to the securities business. All comments are the EXPRESS opinion of the Author, ALL RIGHTS RESERVED